1. Andoh, T., Chargaff, E.: Formation and fate of abnormal ribosomes of E. coli cells treated with 5-fluorouracil. Proc. nat. Acad. Sci. (Wash.) 54, 1181–1189 (1965).
2. Ansfield, F. J., Ramirez, G.: Phase I and II studies of 2’-deoxy-5-(trifluoromethyl)uridine. Cancer Chemother. Rep. 55, 205–208 (1971).
3. Ansfield, F. J., Ramirez, G., Davis, H. L., Jr., Korbitz, B. C., Vermtod, H., Gollin, F. F.: Treatment of advanced cancer of the head and neck. Cancer 25, 78–82 (1970).
4. Ansfield, F. J., Ramirez, G., Korbitz, B. C., Davis, H. L., JR.: Five-drug therapy for advanced breast cancer. A phase I study. Cancer Chemother. Rep. 55, 183–187 (1971a).
5. Ansfield, F. J., Ramirez, G., Mackman, S., Bryan, G.T., Curreri, A. R.: A ten year study of 5-fluorouracil in disseminated breast cancer with clinical results and survival times. Cancer Res. 29, 1062–1066 (1969).